To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open530.75
High530.75
Low530.75
Prev. Close541.55
Avg. Traded Price530.75
Volume2,990

MARKET DEPTH

info2
Total bid0.00
Total ask23,105.00
OrdersQtyBid
000
000
000
000
000
AskQtyOrders
530.759613511
530.83280
5315547
531.2129
5321295

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

530.757 hours ago
530.757 hours ago
arrow

LOWER/UPPER CIRCUITS

530.75
552.35
arrow
Venus Remedies Limited Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 9.11%, in the last year to ₹668.85 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteAnnual Net Profit,rose 59.07% in the last year to ₹45.32 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
notePrice to Earning Ratio,is 15.97, lower than its sector PE ratio of 43.54.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 58.09%
Net profit growth 5Y CAGR : %
Venus Remedies Limited is a research and innovation-driven Indian pharmaceutical company with a global footprint in many nations. The company has several manufacturing facilities, hundreds of market authorisations, many global patents and product basket. Its GLP-accredited Venus Medicine Research Centre (VMRC) is committed to offering the world novel breakthroughs catering to the critical care and super specialty segments. Its manufacturing facilities deliver world-class products accepted by regulators in advanced and developing pharmaceutical markets.
personal

Grow your wealth with more research recommendations

+91